Md. stem cell company using $750000 to move toward commercialization, IPO – Baltimore Business Journal
Baltimore Business Journal |
Md. stem cell company using $750000 to move toward commercialization, IPO
Baltimore Business Journal … $750,000 in state funds to develop… more. Courtesy of TissueGene Inc. TissueGene Inc. was one of 29 entities to be awarded state funding through Maryland Technology Development Corp. to support research and development of stem cell therapies. |
